Patients were randomly assigned to a control group receiving placebo ( n = @ ) , two groups receiving orally administered rosuvastatin ( @ and @mg/daily for @ days ; n = @ for each group ) , a group receiving BPF alone orally ( @ mg/daily for @ days ; n = @ ) and a group receiving BPF ( @ mg/daily given orally ) plus rosuvastatin ( @mg/daily for @ days ; n = @ ) .